# Intrauterine Injection of Type III Collage in FST of EC/AEH

> **NCT07377734** · PHASE2 · RECRUITING · sponsor: **Wang Jianliu** · enrollment: 30 (estimated)

## Conditions studied

- Atypical Endometrial Hyperplasia
- Endometrial Cancer

## Interventions

- **DRUG:** Recombinant Humanized Type III Collagen Lyophilized Fibers + High-dose Progestin
- **DRUG:** High-dose Progestin

## Key facts

- **NCT ID:** NCT07377734
- **Lead sponsor:** Wang Jianliu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377734, "Intrauterine Injection of Type III Collage in FST of EC/AEH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07377734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*